Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Approximately one third of patients with HCC whose tumors express FGF19 together with FGFR4 and its coreceptor klotho β (KLB) could potentially respond to treatment with an FGFR4 inhibitor
6-diyn-10-yl]carbamate
MPQX hydrate
CAS Number: 106463-17-6
IC50 value: 0
Mutated EGFR-IN-2 - CAS# 2050906-97-1 Size:Contact [email protected] for quotation Approximately one third of patientsMutated EGFR IN 2 (compound 91) is a mutant selective EGFR inhibitor extracted from patent WO2017036263A1, which potently inhibits single mutant EGFR (T790M) and double mutant EGFR (including L858R T790M (IC50=1nM) and ex19del T790M), and can suppress activity of single gain of function mutant EGFR (including L858R and ex19del) as well. Mutated EGFR IN 2 shows anti tumor antivity. Product information CAS Number: 2050906 97 1 Molecular Weight: 562. 64
US$ 1300.00
US$ 900.00
US$ 440.00
US$ 1400.00
US$ 325.00
US$ 1400.00
US$ 175.00
US$ 900.00
US$ 440.00
US$ 900.00
US$ 440.00
US$ 125.00
US$ 59.00
US$ 120.00
US$ 1300.00